Zouina Sarfraz: We examined survival outcomes for Stage IV gastric cancer patients with Krukenberg tumors

Zouina Sarfraz, Associate Editor at European Journal of Medical Research, shared a post on LinkedIn:

“I’m thrilled to share my latest research titled ‘Survival Outcomes in Stage IV Gastric Cancer Patients with Krukenberg Tumors: A Systematic Review and Meta-Analysis’ is now published in the Journal of Gastrointestinal Cancer.

Our study examined survival outcomes for Stage IV gastric cancer patients with Krukenberg tumors, comparing standard chemotherapy, surgical resection, and combined treatments. Analyzing data from 1502 patients across 17 studies, we found that overall survival (OS) was 6.7 months with chemotherapy only, 12.8 months with surgery, and 16.2 months with combined treatments. These findings show that combining chemotherapy and surgery offers the best survival benefit.

We hope this research contributes to more informed and patient-centric approaches in oncology.”

Read further.
Source: Zouina Sarfraz/LinkedIn